Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Todd

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Blood|July 1, 1987
Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemiaM B Todd, J A Waldron, T A Jennings, et al.
Blood|January 25, 1992
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaP H Wiernik, P L Banks, D C Case, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigenR S DiPaola, R E Weiss, K B Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2015
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trialsK Fizazi, T W Flaig, M Stöckle, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Blood|July 1, 1987
Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemiaM B Todd, J A Waldron, T A Jennings, et al.
Blood|January 25, 1992
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaP H Wiernik, P L Banks, D C Case, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigenR S DiPaola, R E Weiss, K B Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2015
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trialsK Fizazi, T W Flaig, M Stöckle, et al.
Pageof 2